...
首页> 外文期刊>Archiv der Pharmazie >Synthesis and Acetylcholinesterase/Butyrylcholinesterase Inhibition Activity of 4-Amino-2, 3-diaryl-5, 6, 7, 8-tetrahydrofuro(and thieno)(2, 3-b)-quinolines, and 4-Amino-5, 6, 7, 8, 9-pentahydro-2, 3-diphenylcyclohepta(e)furo(and thieno)-(2, 3-b)pyri
【24h】

Synthesis and Acetylcholinesterase/Butyrylcholinesterase Inhibition Activity of 4-Amino-2, 3-diaryl-5, 6, 7, 8-tetrahydrofuro(and thieno)(2, 3-b)-quinolines, and 4-Amino-5, 6, 7, 8, 9-pentahydro-2, 3-diphenylcyclohepta(e)furo(and thieno)-(2, 3-b)pyri

机译:4-氨基-2、3-二芳基-5、6、7、8-四氢呋喃(和硫代)(2,3-b)-喹啉和4-氨基-5、6的合成和乙酰胆碱酯酶/丁酰胆碱酯酶的抑制活性7、8、9-五氢-2,3-二苯基环庚(e)呋喃(和噻吩)-(2,3-b)吡啶

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibition activities of a series of 4-amino-2, 3-diaryl-5, 6, 7, 8-tetrahydrofuro[2, 3-b]quinolines (10-12)/4-amino-5, 6, 7, 8-tetrahydro-2, 3-diphenylthieno[2, 3-b]quinoline (14) and 4-amino-5, 6, 7, 8, 9-pentahydro-2, 3-diphenylcyclohepta[e]furo[2, 3-b]pyridine (13)/4-amino-5, 6, 7, 8, 9-pentahydro-2, 3-phenylcyclohepta[e]thieno[2, 3-b]pyridine (15) are described. These compounds are tacrine (THA) analogues which have been prepared either from readily available 2-amino-3-cyano-4, 5-diarylfurans (16-18) or from 2-amino-3-cyano-4, 5-diphenylthiophene (19), via Friedlander condensation with cyclohexanone or cycloheptanone. These compounds are competitive inhibitors for acetylcholinesterase, the more potent being compound (13) which is three-fold less active than tacrine. The butyrylcholinesterase inhibition activity is significant only in compounds 10 and133, which are ten-fold less active than tacrine. It is found that the products 11 and 12 strongly inhibit acetylcholinesterase, and show excellent selectivity regarding butyrylcholinesterase.
机译:一系列4-氨基-2、3-二芳基-5、6、7、8-四氢呋喃[2,3-b]喹啉(10-12)/ 4的乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BuChE)抑制活性-氨基-5、6、7、8-四氢-2、3-二苯基噻吩并[2,3-b]喹啉(14)和4-氨基-5、6、7、8、9-五氢-2、3-二苯基环庚[e]呋喃[2,3-b]吡啶(13)/ 4-氨基-5,6,7,8,8,9-五氢-2,3-苯基环庚[e]噻吩并[2,3-b]吡啶(15)被描述。这些化合物是他克林(THA)类似物,它们是由容易获得的2-氨基-3-氰基-4,5-二芳基呋喃(16-18)或2-氨基-3-氰基-4,5-二苯基噻吩( 19),通过弗里德兰德与环己酮或环庚酮缩合。这些化合物是乙酰胆碱酯酶的竞争性抑制剂,更有效的是活性比他克林低三倍的化合物(13)。丁酰胆碱酯酶的抑制活性仅在化合物10和133中显着,其活性比他克林低十倍。发现产物11和12强烈抑制乙酰胆碱酯酶,并且对于丁酰胆碱酯酶显示出优异的选择性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号